Mats Gunnar Pettersson
Director/Board Member bij MAGLE CHEMOSWED HOLDING AB
Profiel
Mats Gunnar Pettersson, oprichter van Swedish Orphan Biovitrum AB, Biovitrum AB en SwedenBIO Service AB, is een Zweedse ondernemer en zakenman die aan het roer heeft gestaan van 7 verschillende bedrijven en lid is van de raad van bestuur van Magle AB, Malthouse Invest AB, Magle Chemoswed AB en Magle Chemoswed Holding AB. Voordien was hij voorzitter van Genmab A, voorzitter van Independent Pharmaceutica AB, voorzitter van Moberg Pharma AB, voorzitter van NsGene A, Chief Executive Officer van Swedish Orphan Biovitrum AB en Chief Executive Officer van Biovitrum AB (een dochteronderneming van Swedish Orphan Biovitrum AB), voorzitter van H. Lundbeck A, Senior Vice President van Pharmacia Corp. en vice-voorzitter van SwedenBIO Service AB. Mats Gunnar Pettersson behaalde een diploma aan de Handelshgskolan i Gteborg.
Actieve functies van Mats Gunnar Pettersson
Bedrijven | Functie | Begin |
---|---|---|
MAGLE CHEMOSWED HOLDING AB | Director/Board Member | 01-01-2016 |
Malthouse Invest AB | Director/Board Member | - |
Magle Chemoswed AB
Magle Chemoswed AB Medical SpecialtiesHealth Technology Part of Maria Magle Holding AB, Magle Chemoswed AB is a Swedish company that designs and develops microspheres medical devices. The private company is based in Lund, Sweden. | Director/Board Member | 01-04-2016 |
Magle AB
Magle AB Chemicals: Major DiversifiedProcess Industries Part of Maria Magle Holding AB, Magle AB is a Swedish company that manufactures chemical products. The private company is based in Lund, Sweden. | Director/Board Member | - |
Eerdere bekende functies van Mats Gunnar Pettersson
Bedrijven | Functie | Einde |
---|---|---|
GENMAB A/S | Chairman | 26-03-2020 |
MOBERG PHARMA AB | Chairman | 18-05-2016 |
PHOTOCURE ASA | Director/Board Member | 01-01-2015 |
H. LUNDBECK A/S | Chairman | 21-03-2013 |
ABLYNX | Director/Board Member | 01-02-2013 |
Opleiding van Mats Gunnar Pettersson
Handelshögskolan i Göteborg | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 7 |
---|---|
H. LUNDBECK A/S | Health Technology |
GENMAB A/S | Health Technology |
PHOTOCURE ASA | Health Technology |
ACTIVE BIOTECH AB | Health Technology |
MOBERG PHARMA AB | Health Technology |
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
MAGLE CHEMOSWED HOLDING AB | Health Technology |
Bedrijven in privébezit | 15 |
---|---|
Biacore International AB
Biacore International AB Pharmaceuticals: MajorHealth Technology Biacore International AB offers systems that generate data on the interactions between proteins and small molecule drug candidates. Its systems are used in pharmaceutical drug discovery, antibody characterization, proteomics, immunogenicity, biotherapeutic development and manufacture and life science research applications. The company serves research centers, pharmaceutical and biotechnology companies. Biacore International markets its products in the United States, Europe, Japan and Australia. The company was founded in 1984 and is headquartered in Uppsala, Sweden | Health Technology |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
Ablynx NV
Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
NsGene A/S
NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | Health Technology |
to-BBB Holding BV
to-BBB Holding BV Pharmaceuticals: GenericHealth Technology to-BBB Holding BV operated as a holding company with interest in providing central nervous system drug technology to the pharmaceutical and biotechnology industries. The firm developed medicines for the treatment of brain diseases. The company was headquartered in The Hague, the Netherlands. | Health Technology |
to-BBB technologies BV
to-BBB technologies BV Pharmaceuticals: MajorHealth Technology BBB Therapeutics BV develops medicines for brain disease treatment. The firm uses its platform technology to enhance the delivery of established and marketed drugs over the blood brain-barrier. It offers its patented central nervous system (CNS) drug targeting technology to their partners in pharmaceutical and biotechnology industry. The firm's products include 2B3-101 and 2B3-201. The company was founded by Pieter Jaap Gaillard, Bert de Boer, and Alfred N. Nijkerk in 2003 and is headquartered in Leiden, the Netherlands. | Health Technology |
Aquapharm Biodiscovery Ltd.
Aquapharm Biodiscovery Ltd. Pharmaceuticals: MajorHealth Technology Aquapharm Biodiscovery Ltd. discovers and develops drugs. It develops products for application across the pharmaceutical, personal care and nutrition sectors. The company offers antibiotics, inflammation & dermatology, oxidative stress, high value ingredients and anti-oxidant ingredients. Aquapharm Biodiscovery was founded by Kathryn Fraser and Andrew Mearns Spragg on April 11, 2000 and is headquartered in Edinburgh, GB. | Health Technology |
Independent Pharmaceutica AB
Independent Pharmaceutica AB Medical DistributorsDistribution Services Independent Pharmaceutica AB is a privately owned company. The major owners are Karolinska Investment Fund, LH Advisory, Sandin &Co and The Foundation for Baltic and East European Studies (Östersjöstiftelsen). Independent Pharmaceutica aims to provide pharmacological solutions for treatment of nicotine addiction. The company is spun out of research from the Karolinska Institutet in Stockholm, Sweden. Tobacco use is the leading preventable cause of morbidity and premature death in the world.Currently over 1.2 billion people smoke worldwide and the number of annual deaths from tobacco-related diseases is over 4 million and rising. The costs for society are huge. With the new vaccine Niccine® against nicotine addiction, the health condition of millions of patients is expected to be improved. | Distribution Services |
SwedenBIO Service AB
SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Commercial Services |
Biacore AB | |
Magle AB
Magle AB Chemicals: Major DiversifiedProcess Industries Part of Maria Magle Holding AB, Magle AB is a Swedish company that manufactures chemical products. The private company is based in Lund, Sweden. | Process Industries |
Malthouse Invest AB | |
Magle Chemoswed AB
Magle Chemoswed AB Medical SpecialtiesHealth Technology Part of Maria Magle Holding AB, Magle Chemoswed AB is a Swedish company that designs and develops microspheres medical devices. The private company is based in Lund, Sweden. | Health Technology |
Metacure Ltd. |